Skip to Primary Navigation

Skip to main content

BMS partners with Anthropic to accelerate life sciences operations, research

A photo of a monitor at the New York Stock Exchange showing Bristol-Myer Squibbs stock information
Photo: Drew Angerer/Getty Images

Kevin Kinsella

2 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

The partnership will introduce Anthropic’s Claude’s agentic AI capabilities into research, clinical development, manufacturing, commercial operations, and corporate functions.

Marking a significant expansion of its use of AI, Bristol Myers Squibb (BMS) has announced a strategic agreement with AI company Anthropic to integrate the Claude Enterprise platform throughout its global operations.

More than 30,000 employees are expected to gain access to the technology.

The partnership will introduce Claude’s agentic AI

, , , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience